Sunnybrook Health Sciences Centre receives $41-million to bolster Canada’s position for clinical trials
Sunnybrook Health Sciences Centre has received a $41-million donation aimed at enhancing clinical trials in Canada. The funding will facilitate faster access to promising therapies and support scientific advancements nationwide. This contribution is expected to transform the delivery of clinical trials and improve patient care across the organization.
- ▪The donation comes from the Weston family, known for their significant business influence in Canada.
- ▪Sunnybrook plans to use the funds to expand specialized teams and create a new integrated management system for clinical trials.
- ▪The initiative aims to make it easier for researchers to initiate new clinical trials and accelerate the process from discovery to patient impact.
Opening excerpt (first ~120 words) tap to expand
Open this photo in gallery:Anaesthesiologist Dr. Chris Idestrup, left, and MRI technologist Ruby Endre monitor a patient as she undergoes maintenance chemotherapy using MRI-guided focused ultrasound treatment.Galit Rodan/The Globe and MailShareSave for laterPlease log in to bookmark this story.Log InCreate Free AccountSunnybrook Health Sciences Centre will receive a $41-million gift that it says will transform the way clinical trials are designed and delivered, leading to improved patient care.The contribution from the Westons, one of the country’s most affluent business families, will mean promising therapies reach patients faster, the Toronto-based centre said.It will also help advance scientific discoveries across the country, said Andy Smith, president and chief executive officer of…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Globe and Mail.
Discussion
0 commentsMore from The Globe and Mail
